Enlivex Therapeutics Ltd.
ENLV | TA
Overview
Corporate Details
- ISIN(s):
- IL0011319527
- LEI:
- Country:
- Israel
- Address:
- Weizmann Science Park, 14 Einstein St., 7403618 Ness Ziona
- Website:
- https://enlivex.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Enlivex develops immunotherapy solutions for inflammatory diseases and critical conditions.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2022-12-07 14:40 |
Inside Information Statement
A Novel Immunotherapy That Could Bring Hope To Millions Of Sepsis Patients Rece…
|
English | 14.8 KB | |
| 2022-12-06 14:00 |
Regulatory News Service
What's Next For Cell Therapy In Oncology? Enlivex (NASDAQ: ENLV) Says It Has Th…
|
English | 13.8 KB | |
| 2022-12-02 14:00 |
Regulatory News Service
First Patients Dosed in Phase I/II Trial of Enlivexs Off-the-Shelf Cell Therapy…
|
English | 15.9 KB | |
| 2022-12-01 20:00 |
Regulatory News Service
Israeli Ministry Of Health Clears Way For Human Trials Of AllocetraTM, A Propri…
|
English | 15.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Gentian Diagnostics ASA | Norway | GENT | |
|
Genus PLC | United Kingdom | GNS | |
|
Grace Breeding Ltd. | Israel | GRAC | |
|
Group 107 Ltd. | Israel | G107 | |
|
Guard Therapeutics International AB | Sweden | GUARD | |
|
Gubra A/S | Denmark | GUBRA | |
|
Hadasit Bio Holding Ltd. | Israel | HDST-M | |
|
Hansa Biopharma | Sweden | HNSA | |
|
HEMOGENYX PHARMACEUTICALS PLC | United Kingdom | HEMO | |
|
Herantis Pharma Oyj | Finland | HRTIS |